Back to User profile » Mr François Laliberté
Papers published by Mr François Laliberté:
Real-World Disability Outcomes Among Patients Treated with Cariprazine vs Other Atypical Antipsychotics as Adjunctive Treatment for Major Depressive Disorder
Masand PS, Parikh M, Ta JT, Wade SW, Haile F, Ripley S, Zanardo E, Spencer CS, Laliberté F, Nabulsi N
ClinicoEconomics and Outcomes Research 2025, 17:585-600
Published Date: 28 August 2025
Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US
Bogart M, Germain G, Laliberté F, Mahendran M, Duh MS, DiRocco K, Noorduyn SG, Paczkowski R, Balkissoon R
Journal of Asthma and Allergy 2023, 16:1309-1322
Published Date: 1 December 2023
Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States
Bogart M, Germain G, Laliberté F, Lejeune D, Duh MS
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1575-1586
Published Date: 24 July 2023
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
Kalhan R, Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, MacKnight SD, Hahn B
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1149-1161
Published Date: 22 April 2021
Characterizing Real-World Use Of Tiotropium In Asthma In The USA
Averell CM, Laliberté F, Duh MS, Wu JW, Germain G, Faison S
Journal of Asthma and Allergy 2019, 12:309-321
Published Date: 7 October 2019
Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population
Bogart M, Stanford RH, Laliberté F, Germain G, Wu JW, Duh MS
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:343-352
Published Date: 19 February 2019
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy
Mapel D, Laliberté F, Roberts MH, Sama SR, Sundaresan D, Pilon D, Lefebvre P, Duh MS, Patel J
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1825-1836
Published Date: 21 June 2017